Retinoid upregulates the sensitivity of cancer cells to a cytokine by inducing the cytokine receptor
Retinoid upregulates the sensitivity of cancer cells to a cytokine by inducing the cytokine receptor
批准号:
13557048
负责人:
MORIWAKI Hisataka
金额:
$6.53万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
无环类维生素A(一种合成的类维生素A类似物)以及干扰素(IFN)-α和-β诱导肝细胞癌(HCC)细胞凋亡,并在临床上用于预防HCC。在这里,我们表明,无环类维生素A协同作用,在抑制生长和诱导细胞凋亡(其特征在于DNA片段化和染色质凝聚)在5个人肝癌细胞系(JHH 7,HuH 7,PLC/PRF/5,HLE和HLF)的干扰素。这种协同作用只观察到细胞预处理的aeyloop类维生素A,而天然视黄酸(全反式和9-顺式视黄酸)是无效的。这种促进作用可能是由于类维生素A上调1型IFN受体(IFNR)的表达。因此,与抗1型IFNR抗体孵育消除了协同作用。增强的IFNR表达伴随着增加的STAT 1(IFNR的细胞内信号转导分子)的表达和DNA结合活性,以及增加的2 ',5'-寡腺苷酸-5 '-三磷酸合成酶(其是STAT 1的靶基因)的诱导。无环类维生素A对正常人肝细胞(Hc)的生长没有任何影响,可能是由于缺乏IFNR和STAT 1的上调。这些结果为使用无环类维生素A和IFN-β联合生物化学预防HCC提供了理论基础。
英文摘要
Acyclic retinoid, a synthetic retinoid analog, as well as interferons (IFNs)-α and -β induce apoptosis in hepatocellular carcinoma (HCC) cells and are used clinically in the prevention of HCC. Here, we show that acyclic retinoid acts synergistically with IFNs in suppressing the growth and inducing apoptosis (as characterized by DNA fragmentation and chromatin condensation) in 5 human HCC cell lines (JHH7,HuH7,PLC/PRF/5,HLE and HLF). This synergism was only observed when cells were pretreated with the aeyclic retinoid, whereas natural retinoic acids (all-trans and 9-cis retinoic acid) were ineffective. This promotion may be due to up-regulation of type 1 IFN receptor (IFNR) expression by the retinoid. Accordingly, incubation with anti-type 1 IFNR antibody abolished the synergy. Enhanced IFNR expression was accompanied by increased expression and DNA-binding activity of STAT1, an intracellular signal transducing molecule of IFNR, and increased induction of 2',5'-oligoadenyl-5'-triphosphate synthetase, which is a target gene of STAT1. Acyclic retinoid did not have any effects on the growth of normal human hepatocytes (Hc) probably due to lack of IFNR and STAT1 up-regulation. These results provide a rationale for combined biochemoprevention of HCC using acyclic retinoid and IFN-β.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Obora A 他: "Synergistic induction of apoptosis by acyclic retinoid and interferon-β in human hepatocellular carcinoma cells"Hepatology. 36. 1115-1124 (2002)
Obora A 等人:“人肝细胞癌细胞中无环类视黄醇和干扰素-β 协同诱导细胞凋亡”,Hepatology,36. 1115-1124 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Adachi S, Okuno M, et al.: "Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma."Hepatology. 35. 332-340 (2002)
Adachi S、Okuno M 等人:“类视黄醇 X 受体的磷酸化可抑制其在人肝细胞癌中的泛素化。”肝病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimizu M, et al.: "Mechanism of retarded liver regeneration in plasminogen activator-deficient mice : Impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic necrosis"Hepatology. 33. 569-576 (2001)
Shimizu M 等人:“纤溶酶原激活剂缺陷型小鼠肝脏再生迟缓的机制:Fas 介导的大规模肝坏死后肝细胞生长因子的活化受损”肝病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Moriwaki H: "Energy metabolism in liver cirrhosis : Its characteristics, clinical significance, and possible intervention : Liver Cirrhosis"Springer-Verlag. (2001)
Moriwaki H:“肝硬化的能量代谢:其特征、临床意义和可能的干预:肝硬化”施普林格出版社。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sueoka E 他: "hn RBP B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia"Cancer Res. 61. 1896-1902 (2001)
Sueoka E 等人:“hn RBP B1 作为人类肺癌隐匿性癌症和支气管发育不良的早期癌症生物标志物”Cancer Res. 61. 1896-1902 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Combination chemoprevention of hepatocellular carcinoma with acyclic retinoid by targeting RXRαphosphorylation
-
批准号:21590838
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:MORIWAKI Hisataka
-
依托单位:
Strategy for chemoprevention of digestive cancers by targeting abnormalities in receptor tyrosine kinases and nuclear receptors
-
批准号:19590720
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:MORIWAKI Hisataka
-
依托单位:
Strategy for the chemoprevention of hepatocellular carcinoma by targeting phosphorylated RXRa
-
批准号:17015016
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$50.88万
-
财政年份:2005
-
负责人:MORIWAKI Hisataka
-
依托单位:
The role of cytokine cascade in impaired liver regeneration and development of candidate pharmaceutical(s) to regulate this mechanism
-
批准号:16590585
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:MORIWAKI Hisataka
-
依托单位:
REGULATION OF HEPATOCARCINOGENESIS BY ACYCLIC RETINOID
-
批准号:11670490
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:MORIWAKI Hisataka
-
依托单位:
MECHANISMS OF CLONAL DELETION OF HEPATOCELLULAR CARCINOMA BY ACYCLICRETINOID
-
批准号:10557055
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.78万
-
财政年份:1998
-
负责人:MORIWAKI Hisataka
-
依托单位:
MECHANISMS OF REGULATION AND CONTROL OF HEPATOCARCINOGENESIS BY ACYCLIC RETINOID
-
批准号:08670576
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1996
-
负责人:MORIWAKI Hisataka
-
依托单位:
GENOMIC MECHANISMS OF REGULATION AND CONTROL OF HEPATOCARCINOGENESIS BY RETINOIDS
-
批准号:05670463
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:MORIWAKI Hisataka
-
依托单位:
海外基金